<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-68095</identifier>
<setSpec>0001-6640</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:description xml:lang="en">Introduction: Chorioamnionitis (CA) has been associated with an increased risk of preterm delivery and adverse neurological outcomes in premature newborn infants. Aim: To determine whether exposure to CA is associated with elevated concentrations of inflammatory cytokines and with increased prevalence of neurological disorders in preterm infants Materials and methods: One hundred fifty-seven preterm infants were studied during the period from 2002 to 2004. Forty-three (27.4%) of these newborns had been exposed to maternal CA. Serum cytokine concentrations (IL6, IL8, TNF) were measured twice, in cord blood and 48 h after delivery. We evaluated the development of perinatal asphyxia and intraventricular haemorrhage, and assessed neurodevelopmental outcomes at the age of 2 years using the Denver Developmental Screening Test. Results: In newborns exposed to CA, compared with thosewithout CA, cord levels of IL6 (26.7 ± 22.2 vs 9.8 ± 6.2 pg/mL)and TNF (50.6 ± 30.1 vs 35.3 ± 21.0 pg/mL) were significantly higher; but there were no differences between the two groupsin terms of either IL8 in cord blood or cytokine values 48 h after delivery. Exposure to CA was associated with a higher risk of a low 5-minute Apgar score (RR 2.3; 95% IC 1.38-3.85; p= 0.001), intraventricular haemorrhage (RR 1.32; 95% IC 1.04-1.67;p= 0.04), and neurodevelopmental disorders as assessed by the Denver test at age the of 2 years (RR 1.57; 95% IC 1.07-2.31; p= 0.002). Conclusions: The results suggest that preterm infants exposedto maternal CA are at a higher risk of poor neurological outcome. Cord blood levels of IL6 and TNF confirm the diagnosis of CA, but show no relation to later neurological findings(AU)</dc:description>
<dc:creator>Larrad Mur, L</dc:creator>
<dc:creator>Pérez González, J. M</dc:creator>
<dc:creator>Lasierra Díaz, M. P</dc:creator>
<dc:creator>Ventura Faci, M. P</dc:creator>
<dc:creator>Samper Villagrasa, M. P</dc:creator>
<dc:creator>Rodríguez Martínez, G</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción: La corioamnionitis (CA) representa un motivo importante de partos pretérmino y complicaciones perinatales, y es causa potencial de parálisis cerebral. Objetivo: Evaluar la relación de la CA con los mediadores inflamatorios y comprobar si aumenta la incidencia de trastornos neurológicos en los recién nacidos (RN) pretérmino. Material y métodos: Estudio de 157 RN pretérmino durante los años 2002-2004, de los cuales 43 (27,4%) eran hijos de madres con CA. Se determinaron la interleucina (IL)-6, la IL-8 y el factor de necrosis tumoral (TNF), tanto en sangre de cordón como a las 48 horas de vida, valorando la asfixia perinatal, la hemorragia intracraneal y el desarrollo neurológico mediante el test de Denver hasta los 2 años de edad. Resultados: En RN con CA frente a RN sin CA, los niveles en sangre de cordón de IL-6 (26,7 ± 22,2 frente a 9,8 ± 6,2 pg/mL)y de TNF (50,6 ± 30,1 frente a 35,3 ± 21,0 pg/mL) fueron significativamente mayores, sin diferencias en la IL-8 en sangre de cordón ni en las determinaciones a las 48 horas. Los hijos de madres con CA presentaron mayor riesgo de tener un test de Apgar bajo a los 5 minutos (riesgo relativo [RR]= 2,3; intervalo de confianza [IC] del 95%: 1,38-3,85; p= 0,001); hemorragia intraventricular (RR= 1,32; IC del 95%: 1,04-1,67; p= 0,04); y trastornos del desarrollo neurológico a los 2 años de edad (RR=1,57; IC del 95%: 1,07-2,31; p= 0,002).Conclusiones: Nuestros resultados sugieren que los hijos de madres con CA presentan mayor riesgo de trastornos del desarrollo neurológico a los 2 años de edad. Las tasas de IL-6 y TNF en sangre de cordón confirman el diagnóstico clínico de CA, aunque carecen de valor pronóstico en la evolución neurológica(AU)</dc:description>
<dc:source>Acta Pediatr Esp;66(4): 176-180, abr. 2008. tab</dc:source>
<dc:identifier>ibc-68095</dc:identifier>
<dc:subject>^d7399</dc:subject>
<dc:subject>^d2871^s22080</dc:subject>
<dc:subject>^d11812</dc:subject>
<dc:subject>^d3971^s22074</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d28903^s22031</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d29472^s22002</dc:subject>
<dc:subject>^d7410^s22080</dc:subject>
<dc:subject>^d2715</dc:subject>
<dc:subject>^d32092^s22045</dc:subject>
<dc:subject>^d2871^s22016</dc:subject>
<dc:subject>^d22228^s22031</dc:subject>
<dc:subject>^d22226</dc:subject>
<dc:subject>^d1244^s22012</dc:subject>
<dc:subject>^d28995^s22002</dc:subject>
<dc:subject>^d28607</dc:subject>
<dc:subject>^d32092^s22083</dc:subject>
<dc:subject>^d1244^s22016</dc:subject>
<dc:subject>^d32092^s22074</dc:subject>
<dc:subject>^d13195</dc:subject>
<dc:subject>^d1040</dc:subject>
<dc:subject>^d32092^s22066</dc:subject>
<dc:type>article</dc:type>
<dc:date>200804</dc:date>
</metadata>
</record>
</ibecs-document>
